BridgeBio Pharma (BBIO) Dividends Paid - Common (2019)
BridgeBio Pharma (BBIO) posted Dividends Paid - Common of $54.0 million for Q4 2019, up 5317.65% sequentially from $997000.0 in Q1 2019.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Dividends Paid - Common (2019) Analysis & Trends
BridgeBio Pharma has reported Dividends Paid - Common for 1 years, with the latest figure at $54.0 million in Q4 2019.
- Quarterly Dividends Paid - Common changed N/A year-over-year to $54.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $55.0 million (changed N/A YoY) and the FY2020 annual result came in at $5.0 million, down 90.91% from the prior year.
- Dividends Paid - Common rose to $54.0 million in Q4 2019 per BBIO's latest filing, from $997000.0 in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $54.0 million in Q4 2019 and troughed at $997000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 34.60 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | BridgeBio Pharma | 14.65 Bn | 13.93 Bn | 228.63 Mn | - |